Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
May 10, 2021 11:25 ET | ALK Abello
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): In accordance with article 19 in Regulation (EU) No...
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
May 10, 2021 11:25 ET | ALK Abello
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af...
ALK_logo_GlobeNewsWire.png
Three-month interim report (Q1) 2021
May 05, 2021 00:57 ET | ALK Abello
ALK reports 9% sales growth in Q1 fuelled by better than expected tablet growth of 32% (unaudited) The first three months of 2021 represented ALK’s best-ever quarter, with revenue exceeding DKK 1...
Three-month interim report (Q1) 2021
May 05, 2021 00:57 ET | ALK Abello
Bemærk venligst, at rapporten foreligger udelukkende på engelsk. ALK reports 9% sales growth in Q1 fuelled by better than expected tablet growth of 32% (unaudited) The first three months of 2021...
ALK_logo_GlobeNewsWire.png
Release date of three-month interim report (Q1) 2021 for ALK and audio cast
April 28, 2021 03:08 ET | ALK Abello
On Wednesday, 5 May 2021, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its three-month interim report (Q1) 2021. ALK will host a meeting for analysts and institutional investors that day at...
Dato for offentliggørelse af delårsrapport for første kvartal 2021 for ALK og webcast
April 28, 2021 03:08 ET | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for første kvartal 2021 onsdag den 5. maj 2021. ALK afholder samme dag kl. 13.30 (CEST) en telefonkonference for investorer og...
ALK_logo_GlobeNewsWire.png
ALK gains paediatric approval for its ragweed SLIT-tablet in the USA
April 19, 2021 05:40 ET | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): The US Food and Drug Administration has approved extending the current product labelling of RAGWITEK® to include paediatric allergic rhinitis patientsThe...
ALK_logo_GlobeNewsWire.png
Grant of share options and performance shares to members of the Board of Management and key employees
March 26, 2021 08:00 ET | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Share option programmeAccording to the Company’s remuneration policy which was once again adopted at the Company's annual general meeting on 18 March...
Tildeling af aktieoptioner og performance-aktier til direktion og ledende medarbejdere
March 26, 2021 08:00 ET | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): AktieoptionsprogramBestyrelsen har i overensstemmelse med Selskabets vederlagspolitik, som blev vedtaget på Selskabets generalforsamling den 18. marts...
ALK_logo_GlobeNewsWire.png
Annual General Meeting in ALK-Abelló A/S held on 18 March 2021
March 18, 2021 12:42 ET | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 18 March 2021. The Annual General Meeting transacted the following business: Adoption of the annual...